Human Health Holdings Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Şu anda Human Health Holdings için büyüme ve gelir tahmini yapmak üzere yeterli analist kapsamımız yok.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Healthcare kazanç büyümesi	18.3%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Recent updates

We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Nov 25

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Sep 13

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Jan 23

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Mar 21

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Nov 26

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Human Health Holdings yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

SEHK:1419 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (HKD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2024	591	24	-26	13	N/A
3/31/2024	603	-22	36	93	N/A
12/31/2023	616	-67	98	172	N/A
9/30/2023	809	57	339	418	N/A
6/30/2023	1,002	181	580	664	N/A
3/31/2023	1,208	367	500	566	N/A
12/31/2022	1,415	553	420	468	N/A
9/30/2022	1,268	464	320	382	N/A
6/30/2022	1,122	375	219	296	N/A
3/31/2022	967	297	232	309	N/A
12/31/2021	813	218	245	322	N/A
9/30/2021	734	181	158	204	N/A
6/30/2021	655	144	71	85	N/A
3/31/2021	542	59	65	76	N/A
12/31/2020	430	-27	59	67	N/A
9/30/2020	442	-33	43	52	N/A
6/30/2020	454	-40	26	37	N/A
3/31/2020	492	-11	29	40	N/A
12/31/2019	530	19	33	42	N/A
9/30/2019	529	23	37	46	N/A
6/30/2019	529	27	42	51	N/A
3/31/2019	523	26	47	56	N/A
12/31/2018	518	25	51	62	N/A
9/30/2018	518	24	45	55	N/A
6/30/2018	518	24	38	47	N/A
3/31/2018	509	22	N/A	45	N/A
12/31/2017	501	19	N/A	42	N/A
9/30/2017	491	16	N/A	32	N/A
6/30/2017	481	13	N/A	22	N/A
3/31/2017	493	16	N/A	22	N/A
12/31/2016	504	19	N/A	22	N/A
9/30/2016	505	21	N/A	21	N/A
6/30/2016	499	23	N/A	21	N/A
9/30/2015	456	36	N/A	44	N/A
6/30/2015	430	34	N/A	55	N/A
6/30/2014	365	39	N/A	41	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 1419 'un tahmini kazanç büyümesinin tasarruf oranının ( 2.3% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.

Kazançlar ve Piyasa: 1419 'un kazançlarının Hong Kong pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Yüksek Büyüme Kazançları: 1419 şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.

Gelir ve Pazar: 1419 şirketinin gelirinin Hong Kong pazarından daha hızlı büyüyeceğinin tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Yüksek Büyüme Geliri: 1419 şirketinin gelirinin yıllık 20% oranından daha hızlı artacağının tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 1419 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Human Health Holdings Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2024

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2022

Human Health Holdings Limited Provides Unaudited Financial Guidance for the Six Months Ended December 31, 2021

Recent updates

We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Full year 2024 earnings released: EPS: HK$0.064 (vs HK$0.48 in FY 2023)

Human Health Holdings Limited Announces Board and Committee Changes

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2024

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Human Health Holdings Limited to Report Q4, 2024 Results on Sep 25, 2024

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2024

First half 2024 earnings released: EPS: HK$0.053 (vs HK$0.71 in 1H 2023)

Human Health Holdings Limited to Report First Half, 2024 Results on Feb 27, 2024

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of HK$0.16 per share at 12% yield

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

New minor risk - Profit margin trend

Human Health Holdings Limited Proposes Final Dividend for the Year Ended June 30, 2023, Payable on 29 December 2023

Human Health Holdings Limited to Report Fiscal Year 2023 Results on Sep 26, 2023

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

Human Health Holdings Limited to Report First Half, 2023 Results on Feb 24, 2023

Investor sentiment improved over the past week

Upcoming dividend of HK$0.30 per share

Less than half of directors are independent

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Investor sentiment improved over the past week

Human Health Holdings Limited to Report Fiscal Year 2022 Results on Sep 29, 2022

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Human Health Holdings Limited to Report First Half, 2022 Results on Feb 25, 2022

Human Health Holdings Limited Provides Unaudited Financial Guidance for the Six Months Ended December 31, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of HK$0.12 per share

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

First half 2021 earnings released: EPS HK$0.045 (vs HK$0.008 in 1H 2020)

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Human Health Holdings Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: HK$0.68

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

New 90-day low: HK$0.55

New 90-day low: HK$0.58

New 90-day low: HK$0.60

Human Health Holdings Limited Resolves Not to Declare Any Final Dividend for Financial Year 2020

Full year earnings released - HK$0.11 loss per share

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin